Discover 233 paid clinical trials in Meridian, Idaho. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Meridian is home to a wide range of active clinical trials focusing on conditions such as diabetes, chronic pain management, and mental health research. Participants in these trials gain access to the latest healthcare innovations while helping shape the future of medical treatments. The city's leading research institutions offer numerous opportunities for both healthy volunteers interested in paid trials and individuals looking for studies targeting specific conditions.
Filter
2
Filter results
Results: 233
Active & Responsive
VK2735 for Weight Management Phase 3
for
Weight Loss
Location: Meridian ID, Butte MT, Ogden UT, Spokane WA,
Sponsor: Viking Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07104500
Phase3, Recruiting
Active & Responsive
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
for
Asthma
Location: Boise ID, Pleasant View UT, South Ogden UT,
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Sex: All
Age: 12+
Code: NCT06664619
Phase3, Recruiting
Active & Responsive
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
for
Coronavirus Disease (COVID-19)
Location: Boise ID, Carson City NV, Redmond WA, San Francisco CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06667700
Phase3, Recruiting
New
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Location: Boise ID, Spokane WA, Salt Lake City UT, Portland OR,
Sponsor: Children's Oncology Group
Sex: All
Age: 365 - 30
Code: NCT03126916
Phase3, Recruiting
Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease
Get alerts for new trials in your area by subscribing now
A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo
for
Alopecia Areata, Vitiligo
Location: Meridian ID, Northridge CA, San Antonio TX,
Sponsor: Dren Bio
Sex: All
Age: 18+
Code: NCT06602232
Phase1, Recruiting
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
for
Myelodysplastic Syndrome
Location: Meridian ID, Boise ID, Nampa ID, Fruitland ID,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06577441
Phase2, Recruiting
A Study to Evaluate the Safety and Immunogenicity of the mRNA COVID-19 Vaccines in Healthy Children Between 6 Months to Less Than 6 Years of Age
for
SARS-CoV-2
Location: Meridian ID, Montebello CA, Albuquerque NM, Lincoln NE,
Sponsor: ModernaTX, Inc.
Sex: All
Age: 6 - 5
Code: NCT05436834
Phase3, Recruiting
A Phase 2b, Randomized, Double-blind, Active-controlled Study of Single Dose CVXGA Intranasal COVID-19 Vaccine in Adults
for
COVID-19
Location: Meridian ID, West Jordan UT, Sacramento CA,
Sponsor: CyanVac LLC
Sex: All
Age: 18 - 70+
Code: NCT06742281
Phase2, Recruiting
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia
Location: Meridian ID, Boise ID, Nampa ID, Fruitland ID,